Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
2.
Herzschrittmacherther Elektrophysiol ; 27(2): 143-50, 2016 Jun.
Artículo en Alemán | MEDLINE | ID: mdl-27206630

RESUMEN

Catheter ablation is an established treatment of supraventricular tachycardias (SVT) with high success rates of > 95 %. Complication rates range from 3 to 5 %, with serious complications occurring in about 0.8 %. There are general complications caused either by the vascular access or the catheters (e. g. hematomas, hemo-pneumothorax, embolism, thrombosis and aspiration) und specific ablation related complications (e. g. AV block during ablation of the slow pathway). The complication risk is elevated in elderly and multimorbid patients. Furthermore, the experience of the treating physician and the respective team plays an essential role. The purpose of this article is to give an overview on incidences, causes and management as well as prevention strategies of complications associated with catheter ablation of SVT.


Asunto(s)
Ablación por Catéter/mortalidad , Muerte Súbita Cardíaca/epidemiología , Complicaciones Posoperatorias/mortalidad , Complicaciones Posoperatorias/prevención & control , Taquicardia Supraventricular/mortalidad , Taquicardia Supraventricular/cirugía , Ablación por Catéter/estadística & datos numéricos , Causalidad , Muerte Súbita Cardíaca/prevención & control , Servicios Médicos de Urgencia/métodos , Servicios Médicos de Urgencia/estadística & datos numéricos , Medicina Basada en la Evidencia , Humanos , Incidencia , Factores de Riesgo , Tasa de Supervivencia
3.
J Cardiovasc Magn Reson ; 17: 62, 2015 Jul 16.
Artículo en Inglés | MEDLINE | ID: mdl-26174798

RESUMEN

BACKGROUND: The left ventricular performance index (LVGFI) as a comprehensive marker of cardiac performance integrates LV structure with global function within one index. In a prospective cohort study of healthy individuals the LVGFI demonstrated a superior prognostic value as compared to LV ejection fraction (LVEF). In patients after ST-segment elevation myocardial infarction (STEMI), however, the role of the LVGFI is unknown. Aim of this study was to investigate the relationship between the LVGFI and infarct characteristics as well as prognosis in a large multicenter STEMI population. METHODS: In total 795 STEMI patients reperfused by primary angioplasty (<12 h after symptom onset) underwent cardiovascular magnetic resonance (CMR) at 8 centers. CMR was completed within one week after infarction using a standardized protocol including LV dimensions, mass and function for calculation of the LVGFI. The primary clinical endpoint of the study was the occurrence of major adverse cardiac events (MACE). RESULTS: The median LVGFI was 31.2 % (interquartile range 25.7 to 36.6). Patients with LVGFI < median had significantly larger infarcts, less myocardial salvage, a larger extent of microvascular obstruction, higher incidence of intramyocardial hemorrhage and more pronounced LV dysfunction (p < 0.001 for all). MACE and mortality rates were significantly higher in the LVGFI < median group (p < 0.001 and p = 0.003, respectively). The LVGFI had an incremental prognostic value in addition to LVEF for prediction of all-cause mortality. CONCLUSIONS: The LVGFI strongly correlates with markers of severe myocardial and microvascular damage in patients with STEMI, offering prognostic information beyond traditional cardiac risk factors including the LVEF. TRIALS REGISTRATION: ClinicalTrials.gov: NCT00712101.


Asunto(s)
Imagen por Resonancia Magnética , Contracción Miocárdica , Infarto del Miocardio/diagnóstico , Disfunción Ventricular Izquierda/diagnóstico , Función Ventricular Izquierda , Abciximab , Anciano , Anticuerpos Monoclonales/administración & dosificación , Femenino , Alemania , Humanos , Fragmentos Fab de Inmunoglobulinas/administración & dosificación , Masculino , Persona de Mediana Edad , Infarto del Miocardio/mortalidad , Infarto del Miocardio/fisiopatología , Infarto del Miocardio/terapia , Intervención Coronaria Percutánea , Inhibidores de Agregación Plaquetaria/administración & dosificación , Valor Predictivo de las Pruebas , Estudios Prospectivos , Factores de Riesgo , Volumen Sistólico , Factores de Tiempo , Resultado del Tratamiento , Disfunción Ventricular Izquierda/mortalidad , Disfunción Ventricular Izquierda/fisiopatología , Disfunción Ventricular Izquierda/terapia
4.
Minerva Cardioangiol ; 59(2): 171-86, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21368735

RESUMEN

Catheter ablation using radiofrequency energy has become an accepted and safe treatment of cardiac arrhythmias. Nevertheless, it is important to determine the risk-to-benefit ratio of a specific procedure, especially when treating subjects with non-life-threatening cardiac arrhythmias, such as AV-nodal reentrant tachycardia or atrial fibrillation, and efforts have to be made to reduce the incidence of complications associated with these procedures, which are in the vast majority of cases not directly attributable to RF energy application but rather with obtaining peripheral vascular access or intracardiac catheter manipulation. Although complication rates in atrial fibrillation (AF) ablation have decreased with improvements of the ablation technique and a change of ablation concepts since the introduction of this technique, the risk of complication is still considerable and significantly higher compared to ablation procedures of other supraventricular tachycardia, including potentially life-threatening events. The higher incidence of AF ablation associated complications may be explained by the complex technique, the need for trans-septal puncture or extensive manipulation in the thin walled left atrium, as well as possible adverse effects of sedation. Even "new" complications associated with AF catheter ablation were identified, such as pulmonary vein stenosis or atrio-esophageal fistula formation. This article will review general risks and complications that can occur during RF catheter ablation procedures and conscious sedation with a particular attention on AF ablation procedures.


Asunto(s)
Ablación por Catéter/efectos adversos , Fístula Esofágica/etiología , Atrios Cardíacos , Cardiopatías/etiología , Humanos , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/prevención & control , Cuidados Preoperatorios , Tromboembolia/etiología
5.
Herzschrittmacherther Elektrophysiol ; 20(4): 173-8, 2009 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-19936818

RESUMEN

Continuous rhythm monitoring is the gold standard of objective rhythm assessment in patients with atrial fibrillation, thus, facilitating accurate detection of symptomatic and asymptomatic atrial fibrillation. This is of scientific and clinical interest for the understanding of this arrhythmia, the establishment of evidence-based therapeutic approaches, the definition of clinically indicated monitoring strategies, and for decision-making about oral anticoagulation. This article illustrates the importance of continuous monitoring of atrial fibrillation and presents developing technologies with their advantages and limitations as well as initial clinical experience.


Asunto(s)
Fibrilación Atrial/diagnóstico , Electrocardiografía Ambulatoria/instrumentación , Telemetría/instrumentación , Administración Oral , Anticoagulantes/uso terapéutico , Fibrilación Atrial/epidemiología , Fibrilación Atrial/terapia , Estudios Transversales , Técnicas de Apoyo para la Decisión , Electrodos Implantados , Diseño de Equipo , Alemania , Humanos , Cuidados a Largo Plazo , Recurrencia , Reproducibilidad de los Resultados , Medición de Riesgo , Accidente Cerebrovascular/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA